SS
TARS icon

Steve Schonfeld’s Tarsus Pharmaceuticals TARS Stock Holding History

Steve Schonfeld’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.28M Buy
+99,845
New +$6.38M 0.02% 558
2026
Q1 		– Sell
-20,674
Closed -$1.69M – 2657
2025
Q4 		$1.69M Buy
+20,674
New +$1.54M 0.01% 933
2025
Q3 		– Sell
-32,411
Closed -$1.31M – 2572
2025
Q2 		$1.31M Buy
32,411
+19,710
+155% +$887K 0.01% 1193
2025
Q1 		$652K Buy
12,701
+2,901
+30% +$143K ﹤0.01% 1471
2024
Q4 		$543K Sell
9,800
-177,713
-95% -$8.07M ﹤0.01% 1353
2024
Q3 		$6.17M Buy
187,513
+159,376
+566% +$4.48M 0.04% 466
2024
Q2 		$765K Buy
28,137
+12,606
+81% +$424K ﹤0.01% 1318
2024
Q1 		$565K Sell
15,531
-163,983
-91% -$4.82M ﹤0.01% 1436
2023
Q4 		$3.64M Sell
179,514
-64,641
-26% -$1.08M 0.02% 604
2023
Q3 		$4.34M Buy
+244,155
New +$4.32M 0.03% 587

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Steve Schonfeld's TARS Position: Q2 2026 in Review

Steve Schonfeld opened a new position in Tarsus Pharmaceuticals (TARS) in Q2 2026: 99,845 shares worth $6.28M. The stake represents 0.02% of the portfolio and ranks #558 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in TARS as recently as Q4 2025.

Steve Schonfeld first reported a position in TARS in Q3 2023 and has held it in 10 quarters since. 256 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Steve Schonfeld held 99,845 shares of Tarsus Pharmaceuticals worth $6.28M as of Q2 2026.
  • Tarsus Pharmaceuticals was a new Steve Schonfeld position in Q2 2026.
  • Tarsus Pharmaceuticals made up 0.02% of Steve Schonfeld's portfolio in Q2 2026, its #558 holding.
  • Steve Schonfeld first reported a position in Tarsus Pharmaceuticals in Q3 2023 and has held it in 10 quarters since.
  • 256 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.